---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-129266"
form_type: "8-K"
ticker: "REPL"
cik: "0001737953"
company_name: "Replimune Group, Inc."
filed_at: "2023-12-26T23:59:59+00:00"
generated_at: "2026-06-07T07:25:21.084712+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Replimune amends Hercules loan: extends revenue milestone to 2026, adjusts tranches up to $50M

## Summary
- Second tranche cut from $45M to $15M (funded Dec 22, 2023); third tranche raised to $30M, extended to Mar 2025.
- Fourth tranche increased from $35M to $50M; fifth tranche increased from $40M to $50M, both extended to Mar 2026 and Sep 2026 respectively.
- Revenue milestone date for triggering loan conditions extended from prior date to July 31, 2026.
- Amendment with Hercules Capital as agent; terms affect up to $145M in potential future advances.

## SEC filing metadata
- accession: 0001104659-23-129266
- form_type: 8-K
- ticker: REPL
- cik: 0001737953
- company_name: Replimune Group, Inc.
- filed_at: 2023-12-26T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737953/000110465923129266/0001104659-23-129266-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737953/000110465923129266/tm2333710d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-129266
- JSON: https://secwatch.observer/filing/0001104659-23-129266.json
- Plain text: https://secwatch.observer/filing/0001104659-23-129266.txt

## Key facts
- Debt Financings
  Replimune Group, Inc. amended credit facility of the second loan tranche advance under the Loan Agreement was decreased from $45 million to $15 million, (ii) the third l with Hercules Capital, Inc..
  - Instrument: credit facility
  - Principal: the second loan tranche advance under the Loan Agreement was decreased from $45 million to $15 million, (ii) the third l
  - Counterparty: Hercules Capital, Inc.
  - Event: amendment
  source text: the revenue milestone date thereunder to July 31, 2026. In addition, pursuant to the Amendment, (i) the second loan tranche advance under the Loan Agreement was decreased from $45 million to $15 million, (ii) the third loan tranche advance under the Loan Agreement was increased from $25 million to $30 million and the availability of the tranche was extended until
  evidence_url: https://www.sec.gov/Archives/edgar/data/1737953/000110465923129266/0001104659-23-129266-index.htm
- Material Agreements
  Replimune Group, Inc. amended Second Amendment to Loan and Security Agreement with Hercules Capital, Inc., as administrative agent and collateral agent, and certain other financial institutions as lenders (effective 2023-12-22).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: Hercules Capital, Inc., as administrative agent and collateral agent, and certain other financial institutions as lenders
  - Effective: 2023-12-22
  source text: On December 22, 2023 (the “Closing Date”), Replimune Group, Inc. (the “Company”) and certain subsidiaries of the Company (collectively, the “Borrowers”) entered into a Second Amendment to Loan and Security Agreement (the “Amendment”) with Hercules Capital, Inc. (“Hercules”), in its capacity as administrative agent and collateral agent (the “Agent”), and certain other financial institutions that from time to time may become parties to the Loan Agreement as lenders (collectively, the “Lenders”) , pursuant to which the Company, Hercules, and the Lenders agreed to amend the Loan and Security Agreement dated October 6, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1737953/000110465923129266/0001104659-23-129266-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.